TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched Glyburide Tablets USP on the TruPharma label. The product is available in 1.25 mg, 2.5 mg and 5 mg strengths. The FDA-approved product is being supplied to TruPharma pursuant to an agreement with Pharmadax USA, Inc. (a subsidiary of Pharmadax, Inc.).